Venita Gresham

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The inability to predict the pharmacology and toxicology of drug candidates in preclinical studies has led to the decline in the number of new drugs which make it to market and the rise in cost associated with drug development. Identifying molecular interactions associated with therapeutic and toxic drug effects early in development is a top priority.(More)
  • 1